| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |